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Reverse Engineering a Kinetic Model of a Dopaminergic Neuron to
Apoptosis
Parkinson's Disease affects approximately one millions individuals in the United States, with more than
60,000 new cases diagnosed each year. While neurothereaputics continue to make strides in elucidating
the mechanisms by which dopaminergic neurons commit to an apoptosis phenotype, many questions
remain. In this work, we have constructed an ordinary differential equation based mathematical model
of the intra-cellular signaling pathway of fundamental and key species, including DJ-1, Parkin, and Pink1,
involved in the control of cell survival vs apoptosis differentiation. We view the commitment to
apoptosis as a biological switch, and utilize our model to identify the subset of kinetic rate values from
the parameter space that cause the neuron to toggle to apoptosis. The novelty of our model includes (i)
the incorporation of calcium and the IPAS pathway, and (ii) the process of searching the parameter
space to "reverse engineer" the kinetics that generate an apoptosis phenotype. We will present our
intra-cellular signaling pathway wiring diagram, system of ODEs, approach for traversing the parameter
space, and preliminary results that show how only certain combinations of kinetics can produce cell
death. We hope that this work will ultimately help identify how existing therapies affect the signaling
pathway, and in addition, identify potentially new therapeutic targets based on their impact in the
biological switch control system.

